When shoulder care should not start with a cash treatment

A slow ache may improve without a large bill

A slow ache without new weakness may improve with simpler care. You may need a better exercise plan, a change in daily lifting, or more time. Don’t assume a cash treatment must come next. Ask what lower-cost care still makes sense for your shoulder.

A fair try can save you trouble.

A scan finding may not cause the soreness

Scans often show worn or torn tendons in shoulders that still work well. The written report can sound worse than the arm feels. An exam compares the scan with your motion, strength, sleep, and daily limits. Don’t pay to treat something on a scan until the clinician connects it to your soreness.

The exam explains whether the scan matters.

New weakness or fever needs medical care first

New weakness after a hard fall may mean a tear that needs a surgeon’s prompt opinion. A hot, red, swollen shoulder with fever may mean an infection and needs same-day care. Soreness running from your neck into a numb or weak hand needs a doctor’s exam. A cash treatment isn’t the place to start.

Get the cause checked first.

Chest symptoms and major injuries need emergency care

Call emergency services for chest tightness, sweating, nausea, trouble breathing, or pain in your jaw or arm. After a fall, go to an emergency room when the shoulder looks out of place or you can’t move the arm. If severe soreness, redness, leaking fluid, or fever follows a procedure on your shoulder, get medical help right away instead of waiting for a usual office appointment the next day.

These symptoms can’t wait.

Sources

1. In a nationally representative Finnish population sample of 602 adults aged 41-76 who had bilateral 3-Tesla shoulder MRI regardless of symptoms, rotator cuff abnormalities were found in 98.7% of participants (25% tendinopathy, 62% partial-thickness tear, 11% full-thickness tear). Abnormalities were present in 96% of ASYMPTOMATIC shoulders. Only full-thickness tears were more common in symptomatic shoulders, and that difference all but disappeared after adjustment (absolute difference 0.8%, 95% CI -3.4% to 6.0%).

   Ibounig T, et al. — Incidental Rotator Cuff Abnormalities on Magnetic Resonance Imaging.. JAMA Intern Med, 2026. DOI: 10.1001/jamainternmed.2025.7903.

2. A current-concepts review of non-operative management of shoulder osteoarthritis states plainly that biologics such as PRP, bone marrow aspirate concentrate and mesenchymal stem cells 'are helpful in decreasing shoulder pain but neither stopping the progression nor improving OA', and that first-line care is physical therapy with NSAIDs.

   Yamamoto N, et al. — Non-operative management of shoulder osteoarthritis: Current concepts.. J ISAKOS, 2023. DOI: 10.1016/j.jisako.2023.06.002.

3. FDA states verbatim that stem cell, stromal vascular fraction, umbilical cord blood, Wharton's jelly, amniotic fluid and exosome products 'have [not] been approved for the treatment of any orthopedic condition, such as osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain, or shoulder pain.' The only FDA-approved stem cell products in the United States are blood-forming (hematopoietic progenitor) cells from umbilical cord blood, approved only for disorders of blood production, and there are currently NO FDA-approved exosome products.

   U.S. Food and Drug Administration — Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes. FDA (Center for Biologics Evaluation and Research), 2020.

4. A meta-analysis with a formal cost-effectiveness analysis found PRP did not reduce retear risk across all tear sizes (RR 0.87, 95% CI 0.67-1.12) but did for small and medium tears under 3 cm (RR 0.60, 0.37-0.97; number needed to treat 14). At an incremental cost-effectiveness ratio of US$127,893 per quality-adjusted life year, the authors concluded PRP was NOT cost-effective even where it worked.

   Vavken P, et al. — Platelet-Rich Plasma Reduces Retear Rates After Arthroscopic Repair of Small- and Medium-Sized Rotator Cuff Tears but Is Not Cost-Effective.. Am J Sports Med, 2015. DOI: 10.1177/0363546515572777.

5. A systematic review of 87 studies of extra-articular (soft tissue) corticosteroid injection found major adverse events in 0-5.8% and minor adverse events in 0-81% of patients depending on the study. Reported major events included osteomyelitis, cellulitis, tendon ruptures, skin atrophy and hypopigmentation, and one fatal necrotizing fasciitis; increased pain or steroid flare after injection was reported in 19 studies.

   Brinks A, et al. — Adverse effects of extra-articular corticosteroid injections: a systematic review.. BMC Musculoskelet Disord, 2010. DOI: 10.1186/1471-2474-11-206.